TORONTO — Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI NASDAQ: OGI), declared that BAT has designated Ms. Caroline Ferland as a nominee to Organigram’s board of directors (the “Board”). Caroline Ferland is a law firm with extensive global experience aiding multinational businesses to operate with assurance and integrity in very regulated and superior-danger environments. As the very first Group Head of Company Conduct and Compliance for BAT, Caroline led the design and style and implementation of BAT’s world-wide compliance and ethics programme (BAT operates in additional than 150 jurisdictions throughout the earth). Caroline is also expert in running strategic litigation and regulatory investigations. She was awarded the Advocatus Emeritus (Advertisement.E) recognition by the Quebec Bar in 2014. Formerly, she chaired the Board of Directors of the Quebec Department of the Canadian Bar Affiliation, and of the Centre d’accès à l’information juridique. She was also a Director of other Boards, these kinds of as the Fondation Marie-Vincent, the Barreau du Québec and the Barreau de Montréal. Ms. Ferland is a Chartered Director (C.Dir) and recognized Administrateur de sociétés certifié (ASC). Caroline retains a BA in Economics from Université de Sherbrooke, as properly as a B.C.L. and an LL.B Regulation from McGill College. Ms. Ferland’s appointment brings the Company’s total number of directors to ten.
“We are thrilled to welcome Caroline to our Board of Administrators. Her intensive expertise in legal and regulatory matters merged with knowledge with BAT will be a huge asset to our Board”, reported Peter Amirault, Board Chair, Organigram.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ World Pick Current market and TSX shown organization whose wholly-owned subsidiaries include things like: Organigram Inc. and Laurentian Organic Inc., licensed producers of cannabis and cannabis-derived items in Canada, and The Edibles and Infusions Corporation, a licensed company of cannabis-infused smooth chews in Canada.
Organigram is concentrated on developing substantial-top quality, cannabis for people and adult leisure buyers, as effectively as developing global company partnerships to increase the Company’s world wide footprint. Organigram has also produced and obtained a portfolio of lawful adult-use recreational cannabis models, such as Edison, Significant Bag O’ Buds, SHRED, SHRED’ems, Monjour, Laurentian, Tremblant Cannabis and Trailblazer. Organigram operates amenities in Moncton, New Brunswick and Lac-Supérieur, Quebec, with a dedicated edibles producing facility in Winnipeg, Manitoba. The Business is regulated by the Cannabis Act and the Hashish Polices (Canada).
This information release has ahead-on the lookout information and facts. Frequently, but not always, ahead-hunting details can be discovered by the use of phrases this sort of as “plans”, “expects”, “estimates”, “intends”, “anticipates”, “believes” or variants of such text and phrases or state that specified actions, events, or final results “may”, “could”, “would”, “might” or “will” be taken, happen or be achieved. Ahead-looking data requires regarded and unknown dangers, uncertainties and other things that might result in genuine success, activities, effectiveness or achievements of Organigram to vary materially from present-day anticipations or long term results, overall performance or achievements expressed or implied by the ahead-hunting information contained in this news launch. Risks, uncertainties and other factors associated with ahead-hunting information and facts could result in precise activities, benefits, overall performance, prospective customers and opportunities to differ materially from those expressed or implied by these types of ahead-wanting details include aspects and pitfalls as disclosed in the Company’s most latest yearly facts form, management’s discussion and examination and other Company files submitted from time to time on SEDAR (see www.sedar.com) and filed or furnished to the Securities and Trade Commission on EDGAR (see www.sec.gov). Viewers are cautioned not to put undue reliance on these ahead-wanting statements, which discuss only as of the day of this press release. Whilst the Enterprise thinks that the assumptions and components made use of in getting ready the forward-wanting details in this news launch are reasonable, undue reliance must not be put on this sort of data and no assurance can be given that these types of events will arise in the disclosed time frames or at all. The forward-hunting facts provided in this information launch are created as of the day of this information release and the Enterprise disclaims any intention or obligation, apart from to the extent expected by legislation, to update or revise any forward-seeking info, regardless of whether as a end result of new info, upcoming activities or in any other case.
For media inquiries:
Paolo De Luca
Chief Method Officer
For investor inquiries: